Form 4 for HCAT Health Catalyst, Inc.
Accepted 2026-09-16 16:52:48 ET · period of report 2026-09-14 · accession 0001703807-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-16 16:52 | 2026-09-14 | HCAT | Kohl Simeon | CEO, Dir | A - Grant | $0.00 | +2.75M | 2.80M | +5,495% | $0 | |
| 2026-09-16 16:52 | 2026-09-14 | HCAT | Kohl Simeon | CEO, Dir | P - Purchase | $1.79 | +59.0K | 2.86M | +2% | +$105.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-14 | A | A | 2,747,385 | $0.00 | 2,797,385 | D | — | — | (F1) Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2026 Employment Inducement Incentive Plan (the "2026 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2026 Plan, 915,975 RSUs will vest on September 4, 2027 and, thereafter, the remaining RSUs will vest in 8 approximately equal quarterly installments. |
| 2 | Common | Common Stock | 2026-09-14 | P | A | 59,000 | $1.79 | 2,856,385 | D | — | — |